BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 38329812)

  • 1. Prebiotic proanthocyanidins inhibit bile reflux-induced esophageal adenocarcinoma through reshaping the gut microbiome and esophageal metabolome.
    Weh KM; Howard CL; Zhang Y; Tripp BA; Clarke JL; Howell AB; Rubenstein JH; Abrams JA; Westerhoff M; Kresty LA
    JCI Insight; 2024 Feb; 9(6):. PubMed ID: 38329812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prebiotic proanthocyanidins inhibit bile reflux-induced esophageal adenocarcinoma through reshaping the gut microbiome and esophageal metabolome.
    Weh KM; Howard CL; Zhang Y; Tripp BA; Clarke JL; Howell AB; Rubenstein JH; Abrams JA; Westerhoff M; Kresty LA
    bioRxiv; 2023 Aug; ():. PubMed ID: 37662411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cranberry Proanthocyanidins Mitigate Reflux-Induced Transporter Dysregulation in an Esophageal Adenocarcinoma Model.
    Zhang Y; Weh KM; Tripp BA; Clarke JL; Howard CL; Sunilkumar S; Howell AB; Kresty LA
    Pharmaceuticals (Basel); 2023 Dec; 16(12):. PubMed ID: 38139823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proanthocyanidins mitigate bile acid-induced changes in GSTT2 levels in a panel of racially diverse patient-derived primary esophageal cell cultures.
    Weh KM; Turgeon DK; Rubenstein JH; Clarke JL; Howell AB; Chang AC; Kresty LA
    Mol Carcinog; 2022 Mar; 61(3):281-287. PubMed ID: 34758158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of the esophageal microbiota in Barrett's esophagus and esophageal adenocarcinoma.
    Lv J; Guo L; Liu JJ; Zhao HP; Zhang J; Wang JH
    World J Gastroenterol; 2019 May; 25(18):2149-2161. PubMed ID: 31143067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutively Higher Level of GSTT2 in Esophageal Tissues From African Americans Protects Cells Against DNA Damage.
    Ferrer-Torres D; Nancarrow DJ; Steinberg H; Wang Z; Kuick R; Weh KM; Mills RE; Ray D; Ray P; Lin J; Chang AC; Reddy RM; Orringer MB; Canto MI; Shaheen NJ; Kresty LA; Chak A; Wang TD; Rubenstein JH; Beer DG
    Gastroenterology; 2019 Apr; 156(5):1404-1415. PubMed ID: 30578782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma.
    Yen CJ; Izzo JG; Lee DF; Guha S; Wei Y; Wu TT; Chen CT; Kuo HP; Hsu JM; Sun HL; Chou CK; Buttar NS; Wang KK; Huang P; Ajani J; Hung MC
    Cancer Res; 2008 Apr; 68(8):2632-40. PubMed ID: 18413730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA alterations in Barrett's esophagus, esophageal adenocarcinoma, and esophageal adenocarcinoma cell lines following cranberry extract treatment: Insights for chemoprevention.
    Kresty LA; Clarke J; Ezell K; Exum A; Howell AB; Guettouche T
    J Carcinog; 2011; 10():34. PubMed ID: 22279419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cranberry proanthocyanidins modulate reactive oxygen species in Barrett's and esophageal adenocarcinoma cell lines.
    Weh KM; Aiyer HS; Howell AB; Kresty LA
    J Berry Res; 2016; 6(2):125-136. PubMed ID: 27583064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esophageal pepsin and proton pump synthesis in barrett's esophagus and esophageal adenocarcinoma.
    Samuels TL; Altman KW; Gould JC; Kindel T; Bosler M; MacKinnon A; Hagen CE; Johnston N
    Laryngoscope; 2019 Dec; 129(12):2687-2695. PubMed ID: 31046139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms.
    Reavis KM; Morris CD; Gopal DV; Hunter JG; Jobe BA
    Ann Surg; 2004 Jun; 239(6):849-56; discussion 856-8. PubMed ID: 15166964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resident Esophageal Microbiota Dysbiosis Correlates with Cancer Risk in Barrett's Esophagus Patients and Is Linked to Low Adherence to WCRF/AICR Lifestyle Recommendations.
    Zaramella A; Arcidiacono D; Nucci D; Fabris F; Benna C; Pucciarelli S; Fassan M; Fantin A; De Re V; Cannizzaro R; Realdon S
    Nutrients; 2023 Jun; 15(13):. PubMed ID: 37447211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cranberry proanthocyanidins inhibit esophageal adenocarcinoma in vitro and in vivo through pleiotropic cell death induction and PI3K/AKT/mTOR inactivation.
    Kresty LA; Weh KM; Zeyzus-Johns B; Perez LN; Howell AB
    Oncotarget; 2015 Oct; 6(32):33438-55. PubMed ID: 26378019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of NOTCH signaling via DLL1 is mediated by APE1-redox-dependent NF-κB activation in oesophageal adenocarcinoma.
    Chen L; Lu H; Peng D; Cao LL; Ballout F; Srirmajayam K; Chen Z; Bhat A; Wang TC; Capobianco A; Que J; McDonald OG; Zaika A; Zhang S; El-Rifai W
    Gut; 2023 Mar; 72(3):421-432. PubMed ID: 35750470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APE1 redox function is required for activation of Yes-associated protein 1 under reflux conditions in Barrett's-associated esophageal adenocarcinomas.
    Ballout F; Lu H; Chen L; Sriramajayam K; Que J; Meng Z; Wang TC; Giordano S; Zaika A; McDonald O; Peng D; El-Rifai W
    J Exp Clin Cancer Res; 2022 Sep; 41(1):264. PubMed ID: 36045416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cranberry proanthocyanidins induce apoptosis and inhibit acid-induced proliferation of human esophageal adenocarcinoma cells.
    Kresty LA; Howell AB; Baird M
    J Agric Food Chem; 2008 Feb; 56(3):676-80. PubMed ID: 18211022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Microbiota in Esophageal Adenocarcinoma: Pathogenesis, Diagnosis, Prognosis and Therapeutic Implications.
    Dan W; Peng L; Yan B; Li Z; Pan F
    Front Microbiol; 2021; 12():791274. PubMed ID: 35126331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct Microbiota Dysbiosis in Patients with Non-Erosive Reflux Disease and Esophageal Adenocarcinoma.
    Zhou J; Shrestha P; Qiu Z; Harman DG; Teoh WC; Al-Sohaily S; Liem H; Turner I; Ho V
    J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32650561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic Obstructive Pulmonary Disease and the Risk of Esophagitis, Barrett's Esophagus, and Esophageal Adenocarcinoma: A Primary Care Case-Control Study.
    Menon S; Nightingale P; Trudgill N
    J Clin Gastroenterol; 2019; 53(10):e451-e455. PubMed ID: 31008868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From Reflux Esophagitis to Esophageal Adenocarcinoma.
    Souza RF
    Dig Dis; 2016; 34(5):483-90. PubMed ID: 27331918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.